FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

372544007: Pyrimidine analog (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1197837016 Pyrimidine analog (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1207395016 Pyrimidine analogue en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1208207018 Pyrimidine analog en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2805281000005116 Pyrimidinanalog da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


15 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Pyrimidine analog (substance) Is a Antimetabolite (substance) true Inferred relationship Some
Pyrimidine analog (substance) Is a Allergen class false Inferred relationship Some
Pyrimidine analog (substance) Is a Drug allergen false Inferred relationship Some
Pyrimidine analog (substance) Is a Drug pseudoallergen by function false Inferred relationship Some
Pyrimidine analog (substance) Is a Drug allergen false Inferred relationship Some
Pyrimidine analog (substance) Is a Pyrimidine and/or pyrimidine derivative true Inferred relationship Some
Pyrimidine analog (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. A substance that competes with, replaces or inhibits a specific metabolite of a cell and thereby interferes with the cell's normal metabolic functioning. true Inferred relationship Some
Pyrimidine analog (substance) Is a Immunologic agent (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Cytarabine liposome Is a True Pyrimidine analog (substance) Inferred relationship Some
Product containing capecitabine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pyrimidine analog (substance) Inferred relationship Some
pyrimidinanalog The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pyrimidine analog (substance) Inferred relationship Some 1
Capecitabine 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pyrimidine analog (substance) Inferred relationship Some
Capecitabine 150 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pyrimidine analog (substance) Inferred relationship Some
Product containing tegafur and uracil (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pyrimidine analog (substance) Inferred relationship Some
Tegafur 100 mg and uracil 224 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pyrimidine analog (substance) Inferred relationship Some
cytarabin 100 mg/ml injektionsvæske, opløsning, hætteglas a 5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pyrimidine analog (substance) Inferred relationship Some
cytarabin 100 mg/ml injektionsvæske, opløsning, hætteglas a 20 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pyrimidine analog (substance) Inferred relationship Some
cytarabin 20 mg/ml injektionsvæske, opløsning, hætteglas a 25 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pyrimidine analog (substance) Inferred relationship Some
cytarabin 1 g pulver til injektionsvæske, opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pyrimidine analog (substance) Inferred relationship Some
cytarabin 20 mg/ml injektionsvæske, opløsning 5ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pyrimidine analog (substance) Inferred relationship Some
cytarabin 100 mg/ml injektionsvæske, opløsning, hætteglas a 1 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pyrimidine analog (substance) Inferred relationship Some
cytarabin 100 mg/ml injektionsvæske, opløsning, hætteglas a 10 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pyrimidine analog (substance) Inferred relationship Some
cytarabin 100 mg pulver til injektionsvæske, opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pyrimidine analog (substance) Inferred relationship Some
Product containing precisely cytarabine 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pyrimidine analog (substance) Inferred relationship Some
Cytarabine 500mg/vial injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pyrimidine analog (substance) Inferred relationship Some
Cytarabine 1g/vial injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pyrimidine analog (substance) Inferred relationship Some
Cytarabine 2g/vial injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pyrimidine analog (substance) Inferred relationship Some
Cytarabine 10mg/mL suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pyrimidine analog (substance) Inferred relationship Some
liposomalt cytarabin 50 mg/5 ml injektionsvæske, hætteglas a 5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pyrimidine analog (substance) Inferred relationship Some
Gemcitabine (substance) Is a True Pyrimidine analog (substance) Inferred relationship Some
Fluorouracil (substance) Is a False Pyrimidine analog (substance) Inferred relationship Some
Floxuridine (substance) Is a True Pyrimidine analog (substance) Inferred relationship Some
Product containing cytarabine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pyrimidine analog (substance) Inferred relationship Some
cytarabin 500 mg pulver til injektionsvæske, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pyrimidine analog (substance) Inferred relationship Some
cytarabin 1 g/pulver til injektionsvæske, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pyrimidine analog (substance) Inferred relationship Some
cytarabin 2 g/pulver til injektionsvæske, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pyrimidine analog (substance) Inferred relationship Some
Product containing precisely cytarabine 50 milligram/1 milliliter conventional release suspension for injection (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pyrimidine analog (substance) Inferred relationship Some
Product containing azacitidine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pyrimidine analog (substance) Inferred relationship Some
azacitidin 100 mg pulver til injektionsvæske, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pyrimidine analog (substance) Inferred relationship Some
Azacitidine (substance) Is a True Pyrimidine analog (substance) Inferred relationship Some
Capecitabine (substance) Is a False Pyrimidine analog (substance) Inferred relationship Some
Cytarabine (substance) Is a True Pyrimidine analog (substance) Inferred relationship Some
Tegafur (substance) Is a False Pyrimidine analog (substance) Inferred relationship Some
Uracil Is a True Pyrimidine analog (substance) Inferred relationship Some
Decitabine (substance) Is a True Pyrimidine analog (substance) Inferred relationship Some
Fluorouracil sodium Is a False Pyrimidine analog (substance) Inferred relationship Some
Fluorouracil (18-F) (substance) Is a True Pyrimidine analog (substance) Inferred relationship Some
Gemcitabine hydrochloride (substance) Is a True Pyrimidine analog (substance) Inferred relationship Some
Fluoropyrimidine (substance) Is a True Pyrimidine analog (substance) Inferred relationship Some

This concept is not in any reference sets

Back to Start